雌孕激素受体在子宫内膜癌、子宫内膜不典型增生及正常子宫内膜中不同表达的临床意义被引量：14

Clinical Significance on the Expression of Estrogen and Progeste rone Receptors in Endometrial Carcinoma,Atypical Hyperplasia and Normal Endome trium.

下载PDF

导出

摘要为探讨子宫内膜雌激素受体(ER)、孕激素受体(PR)检测的方法及意义,用抗ER、PR单克隆抗体免疫组化SP法检测了26例子宫内膜癌、23例子宫内膜不典型增生、22例正常子宫内膜石蜡切片ER、PR的表达,结果显示,免疫组化SP法检测ER,PR阳性率在正常子宫内膜、不典型增生子宫内膜、子宫内膜癌组织中的分布不同。内膜癌ER、PR含量明显低于正常子宫内膜及不典型增生子宫内膜,正常内膜与不典型增生内膜ER、PR的表达无统计学差异,正常内膜与内膜癌、不典型增生与内膜癌ER、PR表达有统计学差异,反映了肿瘤的生物学行为。免疫组化ER、PR含量SP法测定对临床预后判断,指导治疗有一定的意义。 The purpose of this article is to discuss the meaning and the method of testing the ER/PR. We use the anti - ER, anti - PR monoclonal antibody SP method to detect the ER/PR in 26 cases of the endometrial cancinoma endometrium, 23 cases of the atypical hyperplasia and 22 cases of the normal endometrium respectively.The restdt shows that the SP method to test the ER/PR has different result in carcinoma, atypical hyperplasia and normal endometrium. The expression of ER/PR in carcinoma is distinctly lower than that in the atypical hyperplasia and normal endometrium.Tbere is no significant different between the atypical hyperplasia and normal endometrium of the expression of ER/PR. However, there are significant different in the ER. PR expressions between normal endometrium and endometrial careinonm, and between atypical hyperplasia and endometrial careinoma, reflecting the special biological action of the tumor. SP method to test the expression of ER/PR has some special meaning to estimate the prognosis and supervises the treatment of the carcinoma of the uterine.

作者覃建庆宋一丽李明勋

机构地区黑龙江省大庆市第一医院妇产科

出处《医学研究杂志》 2006年第2期27-29,共3页 Journal of Medical Research

关键词子宫内膜癌子宫内膜不典型增生正常子宫内膜雌激素受体孕激素受体免疫组织化学 Endometrial carcinoma Atypical Hyperplasia Normal Endometrium Estrogen receptor Progestemn receptor hmnunohistochemistry

分类号 R711.74 [医药卫生—妇产科学] R737.33 [医药卫生—肿瘤]

引文网络
相关文献

参考文献5

1[1]Nyholm HCJ,Nielsen AL,Lyndrup J,et al.Biochemical and immunohistochenical estrogen and progesterone receptors in adenomatous hyperplasic and endometrial carcinoma:Correlations with stage and other clinic pathologic features.Am Job stet Gynecol,1992,167:1334.
2[2]KohlbergerPD,Kieback DG,Breitenecker F,etal.Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer:true color compute-assisted image analysis versus subjective scoring.Gynecology oncol,1997,64:404.
3[3]Soper JT,Segreto EM,Novotmy DB,et al.Estrogen and progesterone receptor content of endometrial carcinomas:comparison of total tissue versus cancer component analysis.Gynecol Onclo,1990,36:363.
4韩守威,何斌,唐茜萍,刘珊玲,彭芝兰,曹泽毅.女性生殖系统恶性肿瘤组织胞浆雌激素及孕激素受体的研究[J].中华妇产科杂志,1994,29(1):12-15. 被引量：27
5[5]Carcangiu ML,Chambers JT,Voynick IM,et al.Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma,part Ⅰ:clinical and histological correlations,Am J Clin Pathol,1990,94:247.